An overview of allergens

2019 ◽  
Vol 40 (6) ◽  
pp. 362-365
Author(s):  
Dawn K. Lei ◽  
Leslie C. Grammer

Most allergens are proteins or glycoproteins that range in molecular weight from 5000 to 100,000 Da, although polysaccharides and low-molecular-weight substances may also be allergenic. Common allergens include pollens, fungal spores, house-dust mites, and animal epithelial materials but can also include drugs, biologic products, and insect venoms. The allergic response is dependent on the route of exposure. If the exposure is to an inhaled aeroallergen, then the allergic response will be respiratory in nature. Ingested or injected exposure gives rise to gastrointestinal, cutaneous, or anaphylactic reactions. The size of the pollen determines the clinical manifestation of allergy. For example, particles between 20 and 60 μm in diameter can be carried by the wind and cause nasal and ocular symptoms (allergic rhinoconjunctivitis). Particles of <7 μm can deposit in the airways and cause symptoms of asthma. Animals produce allergens in forms unique to each species. Cat allergen, most importantly Fel d 1, is buoyant and “sticky,” which means it easily remains airborne and may last in a home for up to 6 to 9 months after the source is removed. Cat allergen adheres to clothes and can be found in public places, e.g., schools. Dog allergen, particularly Can f 1, is present in dander, saliva, urine, and serum. All dog breeds produce allergenic proteins (even poodles and “hairless” dogs).

2016 ◽  
Vol 8 (11) ◽  
pp. 24 ◽  
Author(s):  
Dan Norbäck ◽  
Gui-Hong Cai ◽  
Ivan Kreft ◽  
Gunilla Wieslander

<p><strong>PURPOSE:</strong> To study associations between cat, dog and horse allergens in day care centres and fractional exhaled nitric oxide (FeNO), eosinophilic cationic protein (ECP) in serum, lung function (FEV<sub>1</sub>) and dyspnoea in day care centre staff. Totally 62 subjects, all females, from five Swedish day care centres participated (participation rate 90%).</p><p><strong>METHODS:</strong> Dust was collected by vacuum cleaning and Petri dish sampling and analysed for cat (Fel d 1), dog (Can f 1) and horse (Ecu cx) allergens by ELISA. Dyspnoea was measured on an analogue rating scale. FeNO, serum ECP and symptom ratings were log-transformed. Associations were analysed by linear mixed models, adjusting for personal and home environment factors.<em> </em></p><p><strong>RESULTS:</strong><em> </em>Geometric mean (GM) value for allergens in vacuumed dust were 1199 ng/g for Fel d 1, 666 ng/g for Can f 1 and 478 U/g for Equ cx, respectively. GM value for allergens in Petri dish samples (ng/m<sup>2</sup> per day) was 29.8 for Fel d 1 and 9.1 for Can f 1, respectively. Cat allergen (Fel d 1) were positively associated with FeNO both in vacuumed dust (p=0.03) and in Petri dish samples (p=0.03). Dog allergen (Can f 1) in Petri dish samples was negatively associated with FeNO (p=0.02). Horse allergen (Equ cx) in vacuumed dust was negatively associated with FeNO (P=0.03).</p><p><strong>CONCLUSION:</strong> Cat, dog and horse allergens were commonly found and cat allergen in day care centres can be a risk factor for lower airway inflammation, measured as FeNO, while dog and horse allergens were associated with lower FeNO.</p>


2004 ◽  
Vol 114 (1) ◽  
pp. 111-117 ◽  
Author(s):  
Samuel J Arbes ◽  
Richard D Cohn ◽  
Ming Yin ◽  
Michael L Muilenberg ◽  
Warren Friedman ◽  
...  

2022 ◽  
Vol 2 ◽  
Author(s):  
Nicole F. Brackett ◽  
Anna Pomés ◽  
Martin D. Chapman

Genome engineering with clustered regularly interspaced short palindromic repeats (CRISPR) technology offers the unique potential for unequivocally deleting allergen genes at the source. Compared to prior gene editing approaches, CRISPR boasts substantial improvements in editing efficiency, throughput, and precision. CRISPR has demonstrated success in several clinical applications such as sickle cell disease and β-thalassemia, and preliminary knockout studies of allergenic proteins using CRISPR editing show promise. Given the advantages of CRISPR, as well as specific DNA targets in the allergen genes, CRISPR gene editing is a viable approach for tackling allergy, which may lead to significant disease improvement. This review will highlight recent applications of CRISPR editing of allergens, particularly cat allergen Fel d 1, and will discuss the advantages and limitations of this approach compared to existing treatment options.


2020 ◽  
Author(s):  
Katarzyna Smejda ◽  
Joanna Jerzyńska ◽  
Daniela Podlecka ◽  
Agnieszka Brzozowska

Abstract Background: Sensitization to cat and/or dog allergens during childhood represents a risk factor for the development of allergic diseases later in life.Material and Methods: The study investigated the association of patterns of sensitization to cat and dog allergen components with clinical symptoms of allergy to these furry animals among cat-sensitized children. It included 50 children aged 5-17 years who showed sensitization to cat in the skin prick test. They were considered to have cat allergy if they suffered from one or more allergy symptoms when being exposed to contact with a cat. The children were evaluated for the presence of bronchial asthma, atopic dermatitis and allergic rhinitis. Their mothers completed a questionnaire on pet exposure at home. Levels of serum IgE cat epitopes Fel d (1, 2, 4), as well as dog components Can f (1, 2, 3, 5) were measured in all the studied children.Results: Respiratory symptoms following exposure to the cat allergen were most common in children with Fel d 2 epitope (p = 0.041). After contact with a dog, respiratory symptoms were most common in children with Can f 1 epitope (p = 0.042), eczema in children with sensitization to both Can f 1 (p = 0.009) and Can f 2 (p = 0.002), whereas eye symptoms occurred mostly in children with Can f 3 (p = 0.039).Conclusions: Molecular diagnosis in patients with pet allergy may help clinicians to predict clinical symptoms and their severity.


2021 ◽  
Vol 22 (10) ◽  
pp. 5286
Author(s):  
Jarmila Čelakovská ◽  
Josef Bukač ◽  
Eva Cermákova ◽  
Radka Vaňková ◽  
Hana Skalská ◽  
...  

Background and aim: Progress in laboratory diagnostics of IgE-mediated allergy is the use of component-resolved diagnosis. Our study analyses the results of specific IgE to 295 allergen reagents (117 allergenic extracts and 178 molecular components) in patients suffering from atopic dermatitis (AD) with the use of ALEX2 Allergy Explorer. Method: The complete dermatological and allergological examination, including the examination of the sensitization to molecular components with ALEX2 Allergy Explorer testing, was performed. The statistical analysis of results was performed with these methods: TURF (total unduplicated reach and frequency), best reach and frequency by group size, two-sided tests, Fisher’s exact test, and chi-square test (at an expected minimum frequency of at least 5). Results: Altogether, 100 atopic dermatitis patients were examined: 48 men, 52 women, the average age 40.9 years, min. age 14 years, max. age 67 years. The high and very high level of specific IgE was reached in 75.0% of patients to 18 molecular components: from PR-10 proteins (Aln g 1, Bet v 1, Cor a1.0103, Cor a1.0401, Fag s 1), lipocalin (Can f 1), NPC2 family (Der f 2, Der p 2), uteroglobin (Fel d 1), from Alternaria alternata (Alt a 1), Beta expansin (Lol p 1, Phl p 1), molecular components from Timothy, cultivated rye (Secc pollen) and peritrophin-like protein domain Der p 23. The high and very high level of specific IgE to other lipocalins (Fel d 7, Can f 4), to arginine kinase (Bla g 9, German cockroach), and to allergen extracts Art v (mugwort), and Cyn d (Bermuda grass) reached 52.0% of patients. The severity of AD is in significant relation to the sensitization to molecular components of storage mites (Gly d 2, Lep d 2—NPC2 family), lipocalins (Can f 1, Can f 2, Can f 4, and Can f 6), arginine kinase (Asp f 6, Bla g 9, Der p 20, Pen m 2), uteroglobin (Fel d 1, Ory c 3), Mn superoxide dismutase (Mala s 11), PR-10 proteins (Fag s 1, Mal d 1, Cor a 1.0401, Cor a 1.0103), molecular components of the peritrophin-like domain (Der p 21, Der p 23), and to Secc pollen. In the subgroup of patients suffering from bronchial asthma, the significant role play molecular components from house dust mites and storage mites (Lep d 2, Der p 2, Der f 2—NPC2 family), cysteine protease (Der p 1), peritrophin-like protein domain (Der p 21, Der p 23), enolase from Alternaria alternata (Alt a 6), and Beta expansin Phl p 1. Conclusion: The results of our study demonstrate the detailed profile of sensitization to allergens reagents (allergen extract and molecular components) in patients with atopic dermatitis. We show the significance of disturbed epidermal barrier, resulting in increased penetration of allergens. We confirmed the significant relationship between the severity of AD, the occurrence of bronchial asthma and allergic rhinitis, and high levels of specific IgE to allergen reagents. Our results may be important for regime measures and immunotherapy; Der p 23 shall be considered as an essential component for the diagnosis and specific immunotherapy of house dust mite allergy.


PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0132311 ◽  
Author(s):  
Rodrigo Ligabue-Braun ◽  
Liana Guimarães Sachett ◽  
Laércio Pol-Fachin ◽  
Hugo Verli
Keyword(s):  
Fel D 1 ◽  

2021 ◽  
Vol 180 ◽  
pp. 105809
Author(s):  
Chi Zhang ◽  
Rosario Recacha ◽  
Lloyd W. Ruddock ◽  
Antti Moilanen

Sign in / Sign up

Export Citation Format

Share Document